{
  "client_id": "c4",
  "account_overview": {
    "name": "Pharmaceutical Company C4",
    "arr": 720000,
    "relationship_age_days": 180,
    "industry": "pharmaceutical",
    "geography": "EMEA"
  },
  "swot": {
    "strengths": {
      "count": 3,
      "items": [
        {
          "category": "technical",
          "description": "Successful pharmaceutical search implementation",
          "impact": "high",
          "evidence": [
            {
              "source_artifact": "daily_notes/2025-12-15.md",
              "date": "2025-12-15",
              "excerpt": "C4 praised search performance for pharmaceutical data",
              "confidence": "HIGH"
            }
          ]
        },
        {
          "category": "relationship",
          "description": "Strong technical relationship with IT team",
          "impact": "high",
          "evidence": [
            {
              "source_artifact": "InfoHub/stakeholders/c4/relationship_map.md",
              "date": "2025-12-20",
              "excerpt": "Monthly sync meetings with IT Director Andreas",
              "confidence": "HIGH"
            }
          ]
        },
        {
          "category": "financial",
          "description": "Stable ARR at $720K",
          "impact": "medium",
          "evidence": [
            {
              "source_artifact": "InfoHub/clients/c4/installed_base.md",
              "date": "2025-12-01",
              "excerpt": "Current ARR: $720,000",
              "confidence": "HIGH"
            }
          ]
        }
      ]
    },
    "weaknesses": {
      "count": 2,
      "items": [
        {
          "category": "competitive",
          "description": "Qdrant vector database evaluation in progress",
          "severity": "high",
          "evidence": [
            {
              "source_artifact": "daily_notes/2025-12-18.md",
              "date": "2025-12-18",
              "excerpt": "C4 mentioned testing Qdrant for vector search use cases",
              "confidence": "HIGH"
            }
          ]
        },
        {
          "category": "technical",
          "description": "Limited observability deployment (search only)",
          "severity": "low",
          "evidence": [
            {
              "source_artifact": "InfoHub/clients/c4/installed_base.md",
              "date": "2025-12-01",
              "excerpt": "Deployed products: Search platform, Analytics dashboard (no Observability)",
              "confidence": "HIGH"
            }
          ]
        }
      ]
    },
    "opportunities": {
      "count": 3,
      "items": [
        {
          "type": "expansion",
          "description": "GenAI-powered pharmaceutical search pilot",
          "estimated_arr": 550000,
          "evidence": [
            {
              "source_artifact": "daily_notes/2025-12-22.md",
              "date": "2025-12-22",
              "excerpt": "C4 interested in GenAI search for R&D, estimated $400K-$700K opportunity",
              "confidence": "MEDIUM"
            }
          ]
        },
        {
          "type": "expansion",
          "description": "Neo4j graph database integration",
          "estimated_arr": 400000,
          "evidence": [
            {
              "source_artifact": "daily_notes/2025-12-10.md",
              "date": "2025-12-10",
              "excerpt": "C4 using Neo4j for molecule relationships, integration opportunity",
              "confidence": "MEDIUM"
            }
          ]
        },
        {
          "type": "consolidation",
          "description": "Enterprise-wide platform rollout (currently single BU)",
          "estimated_arr": 800000,
          "evidence": [
            {
              "source_artifact": "InfoHub/clients/c4/account_plan.md",
              "date": "2025-11-15",
              "excerpt": "Currently deployed in R&D only, potential for Manufacturing and Regulatory",
              "confidence": "LOW"
            }
          ]
        }
      ]
    },
    "threats": {
      "count": 2,
      "items": [
        {
          "category": "competitive",
          "description": "Qdrant evaluation could lead to displacement",
          "probability": "medium",
          "impact": "high",
          "evidence": [
            {
              "source_artifact": "daily_notes/2025-12-18.md",
              "date": "2025-12-18",
              "excerpt": "C4 testing Qdrant as potential vector search replacement",
              "confidence": "HIGH"
            }
          ]
        },
        {
          "category": "organizational",
          "description": "IT budget freeze announced for H1 2026",
          "probability": "high",
          "impact": "medium",
          "evidence": [
            {
              "source_artifact": "daily_notes/2025-12-20.md",
              "date": "2025-12-20",
              "excerpt": "Andreas mentioned H1 budget freeze, expansion delayed to H2",
              "confidence": "HIGH"
            }
          ]
        }
      ]
    }
  },
  "risks": [
    {
      "id": "risk_001",
      "severity": "HIGH",
      "category": "competitive",
      "description": "Qdrant evaluation threatens $720K base",
      "date_identified": "2025-12-18"
    },
    {
      "id": "risk_002",
      "severity": "MEDIUM",
      "category": "financial",
      "description": "H1 budget freeze delays expansion",
      "date_identified": "2025-12-20"
    }
  ],
  "thresholds": {}
}
